| Year |
Citation |
Score |
| 2020 |
Arnold SD, Brazauskas R, He N, Li Y, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Hashmi S, Parsons S, Wood WA, Steinberg A, Freytes CO, et al. The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32464284 DOI: 10.1016/J.Bbmt.2020.05.016 |
0.344 |
|
| 2020 |
Cahen VC, Li Y, Getz KD, Elgarten CW, DiNofia AM, Wilkes JJ, Winestone LE, Huang YV, Miller TP, Gramatges MM, Rabin KR, Fisher BT, Aplenc R, Seif AE. Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment. Pediatric Blood & Cancer. e28315. PMID 32391940 DOI: 10.1002/Pbc.28315 |
0.35 |
|
| 2020 |
Li Y, Yuan Y. PA-CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials. Biometrics. PMID 31950483 DOI: 10.1111/Biom.13217 |
0.328 |
|
| 2020 |
McClory S, Cahen VC, Li Y, Duke JL, Monos DS, Ramos M, Bunin N, Getz KD, Seif AE. Celiac Disease Risk Determined By HLA-DQ Genotype Protects Against Gvhd in a Dose-Responsive Manner Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.748 |
0.327 |
|
| 2020 |
Myers RM, Fitzgerald JC, DiNofia A, Wray L, Leahy AB, Li Y, Smith LT, Burrows EK, Ramos M, Motley LS, Khan R, Aplenc R, Grupp SA, Maude SL. Inpatient and Intensive Care Unit Resource Utilization after CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy (CART19) for Pediatric Acute Lymphoblastic Leukemia (ALL) Biology of Blood and Marrow Transplantation. 26: S202-S203. DOI: 10.1016/J.Bbmt.2019.12.695 |
0.342 |
|
| 2019 |
Seif AE, Li Y, Monos DS, Heidemann SC, Aplenc R, Barrett DM, Casper JT, Freedman JL, Grupp SA, Margolis DA, Olson TS, Teachey DT, Keever-Taylor CA, Wang Y, Talano JM, et al. Partially CD3-depleted unrelated and haploidentical donor PSCT has favorable GVHD and survival rates in pediatric hematologic malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31765697 DOI: 10.1016/J.Bbmt.2019.11.022 |
0.353 |
|
| 2019 |
Grewal AS, Li Y, Fisher MJ, Minturn J, Paltin I, Belasco J, Phillips P, Kang T, Lustig RA, Hill-Kayser C. Tumor bed proton irradiation in young children with localized medulloblastoma. Pediatric Blood & Cancer. e27972. PMID 31512390 DOI: 10.1002/Pbc.27972 |
0.317 |
|
| 2019 |
Phillips CA, Bailer J, Foster E, Li Y, Dogan P, Smith E, Reilly A, Freedman J. Evaluation of an automated pediatric malnutrition screen using anthropometric measurements in the electronic health record: a quality improvement initiative. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31286235 DOI: 10.1007/S00520-019-04980-1 |
0.329 |
|
| 2019 |
Barakat LP, Stevens E, Li Y, Reilly A, Deatrick JA, Goldstein NE, Schwartz LA. Evaluation of the Pediatric Research Participation Questionnaire for Measuring Attitudes Toward Cancer Clinical Trials among Adolescents and Young Adults. Journal of Adolescent and Young Adult Oncology. PMID 31025898 DOI: 10.1089/Jayao.2018.0144 |
0.302 |
|
| 2019 |
Linaburg T, Davis AR, Frey NV, Khawaja MR, Landsburg DJ, Schuster SJ, Svoboda J, Li Y, Borovskiy Y, Olson TS, Bagg A, Hexner EO, Babushok DV. Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia. Plos One. 14: e0215021. PMID 30951562 DOI: 10.1371/Journal.Pone.0215021 |
0.334 |
|
| 2019 |
Winestone LE, Getz KD, Rao P, Li Y, Hall M, Huang YV, Seif AE, Fisher BT, Aplenc R. Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment. Leukemia & Lymphoma. 1-9. PMID 30732497 DOI: 10.1080/10428194.2019.1574002 |
0.375 |
|
| 2019 |
Bona KO, Li Y, Winestone L, Getz KD, Huang Y, Fisher B, Desai AV, Richardson T, Hall M, Naranjo A, Henderson TO, Aplenc R, Bagatell R. Poverty and survival in targeted immunotherapy clinical trials. Journal of Clinical Oncology. 37: 10034-10034. DOI: 10.1200/Jco.2019.37.15_Suppl.10034 |
0.367 |
|
| 2019 |
Getz KD, Li Y, Szymczak JE, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MMM, Henry M, Lotterman C, Maloney K, Mian A, Mody R, Raetz EA, et al. Home or Away from Home: A Multi-Institution Study Comparing Medical Outcomes, Patient Perspectives, and Health-Related Quality of Life for Outpatient Versus Inpatient Management after Chemotherapy for Pediatric Acute Myeloid Leukemia Blood. 134: 379-379. DOI: 10.1182/Blood-2019-131761 |
0.365 |
|
| 2019 |
Getz KD, Sung L, Gerbing RB, Alonzo TA, Li Y, Huang YV, Leger KJ, Pollard JA, Cooper TM, Kolb EA, Gamis AS, Aplenc R. Occurrence and Resolution of Anthracycline Cardiotoxicity and Impact on Treatment Outcomes Among Children Treated on the AAML1031 Clinical Trial: A Report from the Children's Oncology Group Blood. 134: 331-331. DOI: 10.1182/Blood-2019-131227 |
0.417 |
|
| 2019 |
Elgarten CW, Li Y, Huang YV, Aplenc R, Hemmer MT, Arora M, Spellman SR, Wang T, Jagasia M, MacMillan ML, Pidala J, Fisher BT, Hall M. Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantation Research (CIBMTR) and the Pediatric Health Information System (PHIS) Blood. 134: 599-599. DOI: 10.1182/Blood-2019-130466 |
0.375 |
|
| 2019 |
Myers RM, Fitzgerald JC, DiNofia AM, Wray L, Barz Leahy A, Li Y, Smith L, Burrows E, Ramos M, Motley LS, Khan RN, Getz KD, Aplenc R, Grupp S, Maude SL. Trends in Inpatient and Intensive Care Resource Utilization after Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia from 2012-2019 Blood. 134: 61-61. DOI: 10.1182/Blood-2019-126724 |
0.389 |
|
| 2019 |
Seif AE, Li Y, Cahen VC, Huang YV, Hall M, Kolb EA, Fisher BT, Aplenc R, Getz KD. Reduced Relapse Risk in Children with Acute Myeloid Leukemia (AML) Who Experience Septic Shock (SS) Blood. 134: 3496-3496. DOI: 10.1182/Blood-2019-122887 |
0.407 |
|
| 2019 |
Li Y, Wang M, Cheung YK. Treatment and dose prioritization in early phase platform trials of targeted cancer therapies Journal of the Royal Statistical Society Series C-Applied Statistics. 68: 475-491. DOI: 10.1111/Rssc.12324 |
0.306 |
|
| 2019 |
Burns JE, Pérez DR, Li Y, García WG, Garcia FJ, Jiménez JPG, Bueno MC, Sánchez J, Hunger SP, Deverlis A, Steenhoff AP, Fisher BT. 1681. Assessment of the Impact of Infectious Events in a Cohort of Pediatric Leukemia Patients in the Dominican Republic Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.1545 |
0.316 |
|
| 2019 |
Myers RM, Fitzgerald J, Elgarten CW, Getz KD, Li Y, Hogan J, Dinofia A, Burrows EK, Aplenc R, Grupp SA, Laskin B, Maude SL. Acute Kidney Injury after Chimeric Antigen Receptor T-Cell Therapy for Pediatric Acute Lymphoblastic Leukemia Biology of Blood and Marrow Transplantation. 25: S168-S169. DOI: 10.1016/J.Bbmt.2018.12.307 |
0.352 |
|
| 2018 |
Li Y, Newton JG, Getz KD, Huang YS, Seif AE, Fisher BT, Aplenc R, Winestone LE. Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia. Pediatric Blood & Cancer. e27583. PMID 30585685 DOI: 10.1002/Pbc.27583 |
0.338 |
|
| 2018 |
Hwang EI, Kool M, Burger PC, Capper D, Chavez L, Brabetz S, Williams-Hughes C, Billups C, Heier L, Jaju A, Michalski J, Li Y, Leary S, Zhou T, von Deimling A, et al. Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017764720. PMID 30332335 DOI: 10.1200/Jco.2017.76.4720 |
0.379 |
|
| 2018 |
Gurunathan A, Desai AV, Bailey LC, Li Y, Choi JK, Rheingold SR. Significance of CNS 2 cerebrospinal fluid status post-induction in pediatric and adolescent patients with acute lymphoblastic leukemia. Pediatric Blood & Cancer. e27433. PMID 30207055 DOI: 10.1002/Pbc.27433 |
0.3 |
|
| 2018 |
Desai AV, Li Y, Getz K, Seif AE, Fisher B, Huang V, Aplenc R, Bagatell R. Resource utilization and toxicities after single versus tandem autologous stem cell rescue in high-risk neuroblastoma using a national administrative database. Pediatric Blood & Cancer. e27372. PMID 30070014 DOI: 10.1002/Pbc.27372 |
0.352 |
|
| 2018 |
Elgarten CW, Arnold SD, Li Y, Huang YV, Riches ML, Gerber JS, Aplenc R, Saber W, Fisher BT. Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation. Infection Control and Hospital Epidemiology. 1-9. PMID 29734957 DOI: 10.1017/Ice.2018.96 |
0.34 |
|
| 2018 |
Getz KD, He C, Li Y, Huang YV, Burstein DS, Rossano J, Aplenc R. Successful merging of data from the United Network for Organ Sharing and the Pediatric Health Information System databases. Pediatric Transplantation. e13168. PMID 29635813 DOI: 10.1111/Petr.13168 |
0.328 |
|
| 2018 |
Citrin R, Getz KD, Li Y, Huang YS, Horowitz JP, Seif AE, Fisher BT, Aplenc R. The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma. British Journal of Haematology. PMID 29611176 DOI: 10.1111/Bjh.15159 |
0.312 |
|
| 2018 |
Fitzgerald JC, Li Y, Fisher BT, Huang YS, Miller TP, Bagatell R, Seif AE, Aplenc R, Thomas NJ. Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. PMID 29528977 DOI: 10.1097/Pcc.0000000000001525 |
0.324 |
|
| 2018 |
Getz KD, Miller TP, Seif AE, Li Y, Huang YV, Fisher BT, Aplenc R. Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia. Plos One. 13: e0192529. PMID 29420604 DOI: 10.1371/Journal.Pone.0192529 |
0.323 |
|
| 2018 |
Winestone LE, Getz KD, Li Y, Burrows E, Scheurer M, Gramatges MM, Wilkes JJ, Miller TP, Seif AE, Grundmeier RW, Rabin KR, Fisher BT, Aplenc R. Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia Blood. 132: 369-369. DOI: 10.1182/Blood-2018-99-120076 |
0.372 |
|
| 2018 |
Barz Leahy A, Elgarten CW, Li Y, Huang YV, Fisher BT, Delp D, Aplenc R, Getz KD. Evaluation of Hospital Admission Patterns in Children Receiving Treatment for Acute Lymphoblastic Leukemia: What Does a Typical Leukemia Experience Look like? Blood. 132: 4763-4763. DOI: 10.1182/Blood-2018-99-119970 |
0.373 |
|
| 2018 |
Myers RM, Getz KD, Li Y, Huang YV, Citrin R, Elgarten CW, Laskin BL, Horowitz JP, Fisher BT, Aplenc R. Comparative Effectiveness of Rasburicase and Allopurinol in Children with Acute Lymphoblastic Leukemia: An Emulated Pragmatic Trial Using Observational Data Blood. 132: 830-830. DOI: 10.1182/Blood-2018-99-114883 |
0.414 |
|
| 2018 |
Cahen VC, Li Y, Burrows E, Elgarten CW, DiNofia AM, Wilkes JJ, Winestone LE, Huang YV, Fitzgerald JC, Gramatges MM, Rabin KR, Fisher BT, Getz KD, Aplenc R, Seif AE. A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort Blood. 132: 3597-3597. DOI: 10.1182/Blood-2018-99-114235 |
0.393 |
|
| 2018 |
Cahen VC, Li Y, Elgarten CW, DiNofia AM, Wilkes JJ, Winestone LE, Huang YV, Gramatges MM, Rabin KR, Fisher BT, Getz KD, Aplenc R, Seif AE. Using Administrative Data to Identify Relapse and Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Lymphoblastic Leukemia (ALL): Validation at Two Centers and Incidence Estimation in a National Cohort Blood. 132: 624-624. DOI: 10.1182/Blood-2018-99-114228 |
0.431 |
|
| 2017 |
DiNofia AM, Seif AE, Devidas M, Li Y, Hall M, Huang YV, Cahen V, Hunger SP, Winick NJ, Carroll WL, Fisher BT, Larsen EC, Aplenc R. Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232. Cancer Medicine. PMID 29274118 DOI: 10.1002/Cam4.1206 |
0.348 |
|
| 2017 |
Citrin R, Horowitz JP, Reilly AF, Li Y, Huang YS, Getz KD, Seif AE, Fisher BT, Aplenc R. Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database. Plos One. 12: e0186960. PMID 29059235 DOI: 10.1371/Journal.Pone.0186960 |
0.337 |
|
| 2017 |
Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Majhail NS, Diaz MA, Freytes CO, et al. Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the U.S. using merged databases. Haematologica. PMID 28818869 DOI: 10.3324/Haematol.2017.169581 |
0.332 |
|
| 2017 |
Winestone LE, Getz KD, Miller TP, Li Y, Huang YS, Seif AE, Fisher BT, Aplenc R. Complications preceding early deaths in Black and White children with acute myeloid leukemia. Pediatric Blood & Cancer. PMID 28727288 DOI: 10.1002/Pbc.26712 |
0.317 |
|
| 2017 |
Miller TP, Li Y, Kavcic M, Getz KD, Huang YV, Sung L, Alonzo TA, Gerbing R, Daves MH, Horton TM, Pulsipher MA, Pollard J, Bagatell R, Seif AE, Fisher BT, et al. Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: A report from the Children's Oncology Group. Haematologica. PMID 28642300 DOI: 10.3324/Haematol.2017.168815 |
0.364 |
|
| 2017 |
Ying GS, Zhang Q, Lan Y, Li Y, Heitjan DF. Cure Modeling in Real-Time Prediction: How Much Does It Help? Contemporary Clinical Trials. PMID 28545934 DOI: 10.1016/J.Cct.2017.05.012 |
0.662 |
|
| 2017 |
Miller TP, Li Y, Getz KD, Dudley J, Burrows E, Pennington J, Ibrahimova A, Fisher BT, Bagatell R, Seif AE, Grundmeier R, Aplenc R. Using electronic medical record data to report laboratory adverse events. British Journal of Haematology. PMID 28146330 DOI: 10.1111/Bjh.14538 |
0.331 |
|
| 2017 |
Horowitz JP, Fisher BT, Szymczack JE, Li Y, Mann JP, Galvelis T, Suarez R, Sack L, He C, Yver H, Stevens A, Arnold SD, Gramatges MMM, Winick N, Hijiya N, et al. A Multicenter Comparison of Rates of Central Venous Catheter-Associated Bloodstream Infections By Central Venous Catheter Type Among Pediatric Patients Receiving Treatment for Newly Diagnosed Acute Myeloid Leukemia Blood. 130: 610-610. DOI: 10.1182/Blood.V130.Suppl_1.610.610 |
0.308 |
|
| 2017 |
Elgarten C, Arnold S, Li Y, Huang YV, Gerber JS, Saber W, Aplenc R, Fisher BT. Center-level variability in broad-spectrum antibiotic prescribing for children undergoing hematopoietic cell transplantion for acute leukemia. Open Forum Infectious Diseases. 4: S277-S278. DOI: 10.1093/Ofid/Ofx163.623 |
0.311 |
|
| 2017 |
Hwang E, Kool M, Burger P, Capper D, Chavez L, Brabetz S, Williams-Hughes C, Billups C, Heier L, Jaju A, Michalski J, Li Y, Zhou T, Leary S, Heideman N, et al. PDCT-05. MOLECULAR DIAGNOSTICS REVEAL 60% HIGHER SURVIVAL FOR MOLECULARLY-VERIFIED VERSUS HISTOPATHOLOGICALLY-DIAGNOSED PEDIATRIC SUPRATENTORIAL CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS AND PINEOBLASTOMAS; A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP ACNS0332 TRIAL Neuro-Oncology. 19: vi184-vi185. DOI: 10.1093/Neuonc/Nox168.749 |
0.309 |
|
| 2017 |
Embry L, Gioia A, Li Y, Han Y, Cullen P, Janss A, Michalski J, Billups C, Noll R, Hardy K. NCOG-15. LONG-TERM IMPACT OF RADIATION DOSE AND VOLUME ON INTELLECTUAL FUNCTIONING (IQ) FOR CHILDREN DIAGNOSED WITH MEDULLOBLASTOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (COG) Neuro-Oncology. 19: vi141-vi141. DOI: 10.1093/Neuonc/Nox168.576 |
0.338 |
|
| 2016 |
Winestone LE, Getz KD, Miller TP, Wilkes JJ, Sack L, Li Y, Huang YS, Seif AE, Bagatell R, Fisher BT, Epstein A, Aplenc R. The Role of Acuity of Illness at Presentation in Early Mortality in Black Children with Acute Myeloid Leukemia. American Journal of Hematology. PMID 27862214 DOI: 10.1002/Ajh.24605 |
0.355 |
|
| 2016 |
Vujkovic M, Aplenc R, Alonzo TA, Gamis AS, Li Y. Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology Group. Frontiers in Genetics. 7: 139. PMID 27547214 DOI: 10.3389/Fgene.2016.00139 |
0.302 |
|
| 2016 |
Getz KD, Miller TP, Seif AE, Li Y, Huang YS, Alonzo T, Gerbing R, Sung L, Hall M, Bagatell R, Gamis A, Fisher BT, Aplenc R. Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report. Cancer Medicine. PMID 27474232 DOI: 10.1002/Cam4.839 |
0.392 |
|
| 2016 |
Wilkes JJ, Hennessy S, Xiao R, Rheingold S, Seif AE, Huang YS, Vendetti N, Li Y, Bagatell R, Aplenc R, Fisher BT. Volume-Outcome Relationships in Pediatric Acute Lymphoblastic Leukemia: Association Between Hospital Pediatric and Pediatric Oncology Volume With Mortality and Intensive Care Resources During Initial Therapy. Clinical Lymphoma, Myeloma & Leukemia. PMID 27246140 DOI: 10.1016/J.Clml.2016.04.016 |
0.324 |
|
| 2016 |
Salazar EG, Li Y, Fisher BT, Rheingold SR, Fitzgerald J, Seif AE, Huang YS, Bagatell R, Aplenc R. Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States. British Journal of Haematology. PMID 27161549 DOI: 10.1111/Bjh.14085 |
0.341 |
|
| 2016 |
Desai AV, Heneghan MB, Li Y, Bunin NJ, Grupp SA, Bagatell R, Seif AE. Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma. Bone Marrow Transplantation. PMID 27159174 DOI: 10.1038/Bmt.2016.84 |
0.364 |
|
| 2016 |
Heneghan MB, Rheingold SR, Li Y, Seif AE, Huang YS, McLeod L, Wells L, Fisher BT, Aplenc R. Treatment of Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma & Leukemia. 16: 223-229.e2. PMID 27021949 DOI: 10.1016/J.Clml.2015.12.009 |
0.341 |
|
| 2016 |
DiNofia AM, Salazar E, Seif AE, Li Y, Huang YV, Bagatell R, Fisher BT, Aplenc R. Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States. Plos One. 11: e0151362. PMID 26978062 DOI: 10.1371/Journal.Pone.0151362 |
0.35 |
|
| 2016 |
Miller TP, Li Y, Kavcic M, Troxel AB, Huang YV, Sung L, Alonzo TA, Gerbing R, Hall M, Daves MH, Horton TM, Pulsipher MA, Pollard JA, Bagatell R, Seif AE, et al. Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26884558 DOI: 10.1200/Jco.2015.65.5860 |
0.34 |
|
| 2016 |
Desai AV, Seif AE, Li Y, Getz K, Fisher BT, Huang V, Mante A, Aplenc R, Bagatell R. Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative Database. Pediatric Blood & Cancer. PMID 26797923 DOI: 10.1002/Pbc.25893 |
0.301 |
|
| 2016 |
Miller TP, Getz KD, Kavcic M, Li Y, Huang YV, Sung L, Alonzo TA, Gerbing R, Daves M, Horton TM, Pulsipher MA, Pollard J, Bagatell R, Seif AE, Fisher BT, et al. A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group. Leukemia & Lymphoma. 1-8. PMID 26727639 DOI: 10.3109/10428194.2015.1088652 |
0.388 |
|
| 2016 |
Arnold SD, Brazauskas R, He N, Li Y, Satwani P, Pulsipher MA, Hall M, Atsuta Y, Dalal JD, Hahn T, Bonfim C, Khera N, Aplenc R, Saber W. Role of Donor Source on Clinical Outcomes and Inpatient Resource Utilization for Hematopoietic Cell Transplantation in Children with Acute Leukemia Blood. 128: 3575-3575. DOI: 10.1182/Blood.V128.22.3575.3575 |
0.329 |
|
| 2016 |
Frick M, Minturn J, Li Y, Hill-Kayser C. Abstract CT120: Radiotherapy in pediatric patients with atypical teratoid rhabdoid tumor of the central nervous system Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct120 |
0.322 |
|
| 2016 |
Michalski J, Vezina G, Burger P, Gajjar A, Pollack I, Merchant T, Fitzgerald T, Booth T, Tarbell N, Shieh I, Williams-Hughes C, Li Y, Billups C, Packer R, Janss A. Mb-109Preliminary Results Of Cog Acns0331: A Phase Iii Trial Of Involved Field Radiotherapy (Ifrt) And Low Dose Craniospinal Irradiation (Ld-Csi) With Chemotherapy In Average Risk Medulloblastoma: A Report From The Children'S Oncology Group Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now076.104 |
0.319 |
|
| 2015 |
Babushok DV, Grignon AL, Li Y, Atienza J, Xie HM, Lam HS, Hartung H, Bessler M, Olson TS. Disrupted lymphocyte homeostasis in hepatitis-associated acquired aplastic anemia is associated with short telomeres. American Journal of Hematology. PMID 26615915 DOI: 10.1002/Ajh.24256 |
0.322 |
|
| 2015 |
Li Y, Hall M, Fisher BT, Seif AE, Huang YS, Bagatell R, Getz KD, Alonzo TA, Gerbing RB, Sung L, Adamson PC, Gamis A, Aplenc R. Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group. Plos One. 10: e0143480. PMID 26606521 DOI: 10.1371/Journal.Pone.0143480 |
0.358 |
|
| 2015 |
Lee GE, Fisher BT, Xiao R, Coffin SE, Feemster K, Seif AE, Bagatell R, Li Y, Huang YV, Aplenc R. Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic Leukemia. Journal of the Pediatric Infectious Diseases Society. 4: 290-296. PMID 26582867 DOI: 10.1093/Jpids/Piu066 |
0.308 |
|
| 2015 |
Getz KD, Miller TP, Seif AE, Li Y, Huang YS, Bagatell R, Fisher BT, Aplenc R. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia. Cancer Medicine. PMID 26105201 DOI: 10.1002/Cam4.481 |
0.39 |
|
| 2015 |
Griffith SD, Shiffman S, Li Y, Heitjan DF. Model-based imputation of latent cigarette counts using data from a calibration study. International Journal of Methods in Psychiatric Research. PMID 26081923 DOI: 10.1002/Mpr.1468 |
0.717 |
|
| 2015 |
Getz KD, Li Y, Alonzo TA, Hall M, Gerbing RB, Sung L, Huang YS, Arnold S, Seif AE, Miller TP, Bagatell R, Fisher BT, Adamson PC, Gamis A, Keren R, et al. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group. Pediatric Blood & Cancer. PMID 25946708 DOI: 10.1002/Pbc.25569 |
0.332 |
|
| 2015 |
Li Y, Zhang Q. A Weibull multi-state model for the dependence of progression-free survival and overall survival. Statistics in Medicine. 34: 2497-513. PMID 25865438 DOI: 10.1002/Sim.6501 |
0.312 |
|
| 2015 |
Miller TP, Troxel AB, Li Y, Huang YS, Alonzo TA, Gerbing RB, Hall M, Torp K, Fisher BT, Bagatell R, Seif AE, Sung L, Gamis A, Rubin D, Luger S, et al. Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 62: 1184-9. PMID 25760019 DOI: 10.1002/Pbc.25475 |
0.363 |
|
| 2015 |
G Salazar E, Bernhardt MB, Li Y, Aplenc R, Adamson PC. The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 62: 940-4. PMID 25704486 DOI: 10.1002/Pbc.25445 |
0.362 |
|
| 2015 |
Li Y, Mick R, Heitjan DF. Suspension of accrual in phase II cancer clinical trials. Clinical Trials (London, England). 12: 128-38. PMID 25568092 DOI: 10.1177/1740774514562029 |
0.537 |
|
| 2015 |
Patterson CA, Chavez V, Mondestin V, Deatrick J, Li Y, Barakat LP. Clinical Trial Decision Making in Pediatric Sickle Cell Disease: A Qualitative Study of Perceived Benefits and Barriers to Participation. Journal of Pediatric Hematology/Oncology. 37: 415-22. PMID 25072368 DOI: 10.1097/Mph.0000000000000216 |
0.309 |
|
| 2015 |
Seif AE, Walker DM, Li Y, Huang YS, Kavcic M, Torp K, Bagatell R, Fisher BT, Aplenc R. Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients. Pediatric Blood & Cancer. 62: 704-9. PMID 24668949 DOI: 10.1002/Pbc.25043 |
0.375 |
|
| 2015 |
Desai AV, Li Y, Heneghan M, Huang Y, Fisher B, Mante A, Grupp SA, Bunin NJ, Aplenc R, Bagatell R, Seif AE. Resource utilization (RU) and toxicities after carboplatin/etoposide/melphalan (CEM) and busulfan/melphalan (BuMel) for autologous stem cell rescue (ASCR) in high-risk neuroblastoma (HRNB). Journal of Clinical Oncology. 33: e21009-e21009. DOI: 10.1200/Jco.2015.33.15_Suppl.E21009 |
0.35 |
|
| 2015 |
Gurunathan A, Desai AV, Bailey LC, Li Y, Choi J, Rheingold SR. Identification of patients with post-induction CNS 2 status and outcomes in acute lymphoblastic leukemia. Journal of Clinical Oncology. 33: 10033-10033. DOI: 10.1200/Jco.2015.33.15_Suppl.10033 |
0.326 |
|
| 2015 |
Miller TP, Li Y, Kavcic M, Alonzo TA, Hall M, Huang Y, Gerbing RB, Fisher B, Luger SM, Rubin D, Troxel AB, Sung L, Gamis AS, Aplenc R. Accuracy of adverse event reporting on a phase III clinical trial for pediatric acute myeloid leukemia: A report from the Children’s Oncology Group. Journal of Clinical Oncology. 33: 10028-10028. DOI: 10.1200/Jco.2015.33.15_Suppl.10028 |
0.383 |
|
| 2015 |
Winestone LE, Getz KD, Miller TP, Wilkes JJ, Sack L, Li Y, Huang Y, Seif AE, Bagatell R, Fisher BT, Epstein A, Aplenc R. Racial Disparities in Pediatric Acute Myeloid Leukemia during Induction Blood. 126: 530-530. DOI: 10.1182/Blood.V126.23.530.530 |
0.341 |
|
| 2015 |
Satwani P, Brazauskas R, Arnold SD, He N, Li Y, Aplenc R, Hall M, Atsuta Y, Dalal JD, Hahn T, Jin Z, Sales-Bonfim C, Khera N, Saber W. A Study of Predictors of Clinical Outcomes and Healthcare Utilization in Children with Sickle Cell Disease Undergoing Allogeneic Hematopoietic Cell Transplantation Blood. 126: 528-528. DOI: 10.1182/Blood.V126.23.528.528 |
0.387 |
|
| 2015 |
Babushok DV, Perdigones N, Perin JC, Olson TS, Ye W, Roth JJ, Lind C, Cattier C, Li Y, Hartung H, Paessler ME, Frank DM, Xie HM, Busse TM, Cross S, et al. Abstract 2977: Most patients with acquired aplastic anemia develop clonal hematopoiesis early in disease Cancer Research. 75: 2977-2977. DOI: 10.1158/1538-7445.Am2015-2977 |
0.313 |
|
| 2014 |
Goodman EK, Reilly AF, Fisher BT, Fitzgerald J, Li Y, Seif AE, Huang YS, Bagatell R, Aplenc R. Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals. Jama Pediatrics. 168: 925-31. PMID 25155012 DOI: 10.1001/Jamapediatrics.2014.1023 |
0.374 |
|
| 2014 |
Freedman JL, Faerber J, Kang TI, Dai D, Fisher BT, Huang YS, Li Y, Aplenc R, Feudtner C. Predictors of antiemetic alteration in pediatric acute myeloid leukemia. Pediatric Blood & Cancer. 61: 1798-805. PMID 24939039 DOI: 10.1002/Pbc.25108 |
0.36 |
|
| 2014 |
Desai AV, Kavcic M, Huang YS, Herbst N, Fisher BT, Seif AE, Li Y, Hennessy S, Aplenc R, Bagatell R. Establishing a high-risk neuroblastoma cohort using the Pediatric Health Information System Database. Pediatric Blood & Cancer. 61: 1129-31. PMID 24616331 DOI: 10.1002/Pbc.24930 |
0.329 |
|
| 2014 |
Maude SL, Fitzgerald JC, Fisher BT, Li Y, Huang YS, Torp K, Seif AE, Kavcic M, Walker DM, Leckerman KH, Kilbaugh TJ, Rheingold SR, Sung L, Zaoutis TE, Berg RA, et al. Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 15: 112-20. PMID 24366507 DOI: 10.1097/Pcc.0000000000000042 |
0.373 |
|
| 2014 |
Fisher BT, Kavcic M, Li Y, Seif AE, Bagatell R, Huang YS, Zaoutis T, Torp K, Leckerman KH, Aplenc R. Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 502-8. PMID 24270167 DOI: 10.1093/Cid/Cit781 |
0.335 |
|
| 2014 |
Seif AE, Fisher BT, Li Y, Torp K, Rheam DP, Huang YS, Harris T, Shah A, Hall M, Fieldston ES, Kavcic M, Vujkovic M, Bailey LC, Kersun LS, Reilly AF, et al. Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatric Blood & Cancer. 61: 846-52. PMID 24249480 DOI: 10.1002/Pbc.24855 |
0.335 |
|
| 2014 |
Fisher BT, Singh S, Huang YS, Li Y, Gregory J, Walker D, Seif AE, Kavcic M, Aplenc R. Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009. Pediatric Blood & Cancer. 61: 68-73. PMID 23868668 DOI: 10.1002/Pbc.24585 |
0.385 |
|
| 2014 |
Fisher BT, Harris T, Torp K, Seif AE, Shah A, Huang YS, Bailey LC, Kersun LS, Reilly AF, Rheingold SR, Walker D, Li Y, Aplenc R. Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data. Medical Care. 52: e1-6. PMID 22410405 DOI: 10.1097/Mlr.0B013E31824Deff9 |
0.382 |
|
| 2014 |
Aplenc R, Fisher B, Li Y, Alonzo TA, Gerbing RB, Hall M, Arnold SD, Huang Y, Seif AE, Bagatell R, Sung L, Adamson PC, Gamis AS, Keren R. Standardized costs and outcome in children treated with gemtuzumab on the AAML0531 trial: A report from the Children’s Oncology Group. Journal of Clinical Oncology. 32: 7086-7086. DOI: 10.1200/Jco.2014.32.15_Suppl.7086 |
0.376 |
|
| 2014 |
Goodman EK, Reilly AF, Li Y, Seif AE, Fitzgerald J, Huang Y, Bagatell R, Fisher B, Aplenc R. Impact of weekend admission on hospital length of stay and organ failure in pediatric leukemia patients at free-standing U.S. children’s hospitals. Journal of Clinical Oncology. 32: 6598-6598. DOI: 10.1200/Jco.2014.32.15_Suppl.6598 |
0.335 |
|
| 2014 |
Bagatell R, Fisher B, Seif AE, Huang Y, Li Y, Desai AV, London WB, Van Ryn C, Park JR, Richardson T, Hall M, Aplenc R. Evaluation of resources used during care of children with high-risk neuroblastoma (HR NBL) via merging of cooperative group trial data and administrative data. Journal of Clinical Oncology. 32: 10069-10069. DOI: 10.1200/Jco.2014.32.15_Suppl.10069 |
0.368 |
|
| 2014 |
Goodman EK, Li Y, Seif AE, Fitzgerald J, Huang Y, Bagatell R, Fisher BT, Aplenc R. Treatment Toxicity and Supportive Care Utilization in Children with Down Syndrome and Acute Lymphoid Leukemia at Free-Standing Pediatric Hospitals in the United States Blood. 124: 553-553. DOI: 10.1182/Blood.V124.21.553.553 |
0.365 |
|
| 2014 |
Getz KD, Miller TP, Seif AE, Li Y, Huang Y, Bagatell R, Fisher BT, Aplenc R. Comparison of Resource Utilization in Children Discharged Versus Children That Remain Hospitalized Following Chemotherapy for Acute Myeloid Leukemia Blood. 124: 3697-3697. DOI: 10.1182/Blood.V124.21.3697.3697 |
0.371 |
|
| 2014 |
Wilkes JJ, Hennessy S, Xiao R, Rheingold SR, Seif AE, Huang Y, Vendetti N, Li Y, Bagatell R, Aplenc R, Fisher BT. Pediatric Hospital Volume and Induction Mortality in Pediatric Acute Lymphoblastic Leukemia (ALL) Blood. 124: 2653-2653. DOI: 10.1182/Blood.V124.21.2653.2653 |
0.355 |
|
| 2014 |
Rao P, Li Y, Alonzo TA, Sung L, Gerbing RB, Getz KD, Seif AE, Miller TP, Huang Y, Bagatell R, Hall M, Fisher BT, Gamis AS, Aplenc R. Patient Factors Associated with Enrollment on an Acute Myeloid Leukemia Phase III Clinical Trial: A Report from the Children’s Oncology Group Blood. 124: 2286-2286. DOI: 10.1182/Blood.V124.21.2286.2286 |
0.413 |
|
| 2014 |
DiNofia AM, Seif AE, Devidas M, Li Y, Hall M, Huang YV, Bagatell R, Carroll WL, Winick NJ, Hunger SP, Fisher BT, Larsen EC, Aplenc R. Resource Utilization and Cost Analysis By Treatment Arm on the Children’s Oncology Group AALL0232 Phase 3 High-Risk B-Precursor Acute Lymphoblastic Leukemia Trial: A Report from the Children’s Oncology Group Blood. 124: 210-210. DOI: 10.1182/Blood.V124.21.210.210 |
0.358 |
|
| 2013 |
Oshrine B, Bunin N, Li Y, Furth S, Laskin BL. Kidney and bladder outcomes in children with hemorrhagic cystitis and BK virus infection after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1702-7. PMID 24060406 DOI: 10.1016/J.Bbmt.2013.09.007 |
0.334 |
|
| 2013 |
Lothstein K, Fisher B, Li Y, Seif A, Harris T, Torp K, Kavcic M, Huang YS, Rheingold SR, Aplenc R. Zoonotic infections in pediatric patients with acute leukemia. Pediatric Blood & Cancer. 60: E160-2. PMID 23956002 DOI: 10.1002/Pbc.24596 |
0.351 |
|
| 2013 |
Babushok DV, Li Y, Roth JJ, Perdigones N, Cockroft JD, Biegel JA, Mason PJ, Bessler M. Common polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients. American Journal of Hematology. 88: 862-7. PMID 23798465 DOI: 10.1002/Ajh.23521 |
0.305 |
|
| 2013 |
Kavcic M, Fisher BT, Li Y, Seif AE, Torp K, Walker DM, Huang YS, Lee GE, Tasian SK, Vujkovic M, Bagatell R, Aplenc R. Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States. Cancer. 119: 1916-23. PMID 23436301 DOI: 10.1002/Cncr.27957 |
0.401 |
|
| 2013 |
Kavcic M, Fisher BT, Seif AE, Li Y, Huang YS, Walker D, Aplenc R. Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States. The Journal of Pediatrics. 162: 1252-8, 1258.e1. PMID 23269206 DOI: 10.1016/J.Jpeds.2012.11.038 |
0.332 |
|
| 2013 |
Wileyto EP, Li Y, Chen J, Heitjan DF. Assessing the fit of parametric cure models. Biostatistics (Oxford, England). 14: 340-50. PMID 23197383 DOI: 10.1093/Biostatistics/Kxs043 |
0.537 |
|
| 2013 |
Kavcic M, Fisher BT, Torp K, Li Y, Huang YS, Seif AE, Vujkovic M, Aplenc R. Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database. Pediatric Blood & Cancer. 60: 508-11. PMID 23192853 DOI: 10.1002/Pbc.24402 |
0.376 |
|
| 2013 |
Fisher BT, Gerber JS, Leckerman KH, Seif AE, Huang YS, Li Y, Harris T, Torp K, Douglas R, Shah A, Walker D, Aplenc R. Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia. Leukemia & Lymphoma. 54: 1633-9. PMID 23163631 DOI: 10.3109/10428194.2012.750722 |
0.339 |
|
| 2013 |
Walker DM, Fisher BT, Seif AE, Huang YS, Torp K, Li Y, Aplenc R. Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database. Pediatric Blood & Cancer. 60: 616-20. PMID 22948886 DOI: 10.1002/Pbc.24270 |
0.398 |
|
| 2013 |
Miller TP, Kavcic M, Li Y, Alonzo TA, Hall M, Huang Y, Gerbing RB, Fisher BT, Luger S, Rubin D, Troxel A, Sung L, Gamis AS, Aplenc R. Accuracy Of Adverse Event Reporting Compared To Patient Chart Abstraction On a Phase III NCI-Funded Clinical Trial For Pediatric Acute Myeloid Leukemia: A Report From The Children’s Oncology Group Blood. 122: 931-931. DOI: 10.1182/Blood.V122.21.931.931 |
0.404 |
|
| 2013 |
Heneghan MB, Rheingold SR, Li Y, Seif AE, Huang Y, Fisher BT, Aplenc R. Avascular Necrosis(AVN) and Surgical Intervention In Pediatric Acute Lymphoblastic Leukemia(ALL): A Retrospective Cohort Analysis From The Pediatric Health Information Systems (PHIS) Blood. 122: 1689-1689. DOI: 10.1182/Blood.V122.21.1689.1689 |
0.32 |
|
| 2013 |
Li Y, Heitjan DF. A note on the complementary mixture Pareto II distribution Communications in Statistics - Theory and Methods. 42: 201-213. DOI: 10.1080/03610926.2011.581787 |
0.482 |
|
| 2012 |
Aplenc R, Fisher BT, Huang YS, Li Y, Alonzo TA, Gerbing RB, Hall M, Bertoch D, Keren R, Seif AE, Sung L, Adamson PC, Gamis A. Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group. Pharmacoepidemiology and Drug Safety. 21: 37-43. PMID 22552978 DOI: 10.1002/Pds.3241 |
0.365 |
|
| 2012 |
Li Y, Mick R, Heitjan DF. A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials. Clinical Trials (London, England). 9: 293-302. PMID 22523304 DOI: 10.1177/1740774512443429 |
0.526 |
|
| 2012 |
Walker DM, Li Y, Huang Y, Seif AE, Kavcic M, Torp K, Fisher B, Aplenc R. Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric cancer patients. Journal of Clinical Oncology. 30: 1504-1504. DOI: 10.1200/Jco.2012.30.15_Suppl.1504 |
0.402 |
|
| 2012 |
Kavcic M, Fisher BT, Li Y, Seif AE, Torp K, Huang Y, Lee GE, Tasian SK, Desai AV, Vujkovic M, Bagatell R, Aplenc R. Mortality and Resource Utilization in Children with De Novo Acute Myeloid Leukemia Treated with Chemotherapy and Gemtuzumab Ozogamicin in the United States Blood. 120: 4283-4283. DOI: 10.1182/Blood.V120.21.4283.4283 |
0.406 |
|
| 2012 |
Kavcic M, Fisher BT, Gerber JS, Leckerman KH, Li Y, Huang Y, Seif AE, Torp K, Bagatell R, Aplenc R. Variability in Antifungal Use for Pediatric Acute Myeloid Leukemia At Children's Hospitals Across the United States Blood. 120: 4278-4278. DOI: 10.1182/Blood.V120.21.4278.4278 |
0.367 |
|
| 2011 |
Li Y, Wileyto EP, Heitjan DF. Statistical analysis of daily smoking status in smoking cessation clinical trials. Addiction (Abingdon, England). 106: 2039-46. PMID 21631623 DOI: 10.1111/J.1360-0443.2011.03519.X |
0.508 |
|
| 2011 |
Li Y, Wileyto EP, Heitjan DF. Prediction of individual long-term outcomes in smoking cessation trials using frailty models. Biometrics. 67: 1321-9. PMID 21401566 DOI: 10.1111/J.1541-0420.2011.01578.X |
0.533 |
|
| 2011 |
Sepe D, Fisher BT, Seif AE, Huang YV, Li Y, Aplenc R. Dexrazoxane Use in Pediatric Patients with Acute Lymphoblastic or Myeloid Leukemia: Analysis of a National Cohort of Patients in the Pediatric Health Information Systems Database From 1999 to 2009 Blood. 118: 4242-4242. DOI: 10.1182/Blood.V118.21.4242.4242 |
0.421 |
|
| 2011 |
Aplenc R, Fisher BT, Sung L, Keren R, Alonzo TA, Hall M, Huang YV, Li Y, Luan X, Gerbing RB, Bertoch D, Seif AE, Adamson PC, Gamis AS. Merging of Children's Oncology Group and Pediatric Health Information Systems Data to Determine Resource Utilization and Treatment Costs on AAML0531: A Report From the Children's Oncology Group Blood. 118: 2617-2617. DOI: 10.1182/Blood.V118.21.2617.2617 |
0.388 |
|
| 2010 |
Li Y, Wileyto EP, Heitjan DF. Modeling smoking cessation data with alternating states and a cure fraction using frailty models. Statistics in Medicine. 29: 627-38. PMID 20077505 DOI: 10.1002/Sim.3825 |
0.544 |
|
| 2010 |
Seif AE, Rheingold SR, Fisher BT, Huang YV, Li Y, Kersun LS, Bailey LC, Reilly AF, Aplenc R. Induction Mortality In Pediatric Acute Lymphoblastic Leukemia (ALL): a Retrospective Cohort Analysis From the Pediatric Health Systems Information (PHIS) Database, 1999–2009 Blood. 116: 3239-3239. DOI: 10.1182/Blood.V116.21.3239.3239 |
0.384 |
|
| Show low-probability matches. |